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1. Introduction
  Leishmaniasis affects 12 million people worldwide and is 
seen in nearly 88 countries. Incidence of leishmaniasis is 
highest in India, Bangladesh, Nepal, Brazil and Sudan. The 
oral mucosal involvement is rare in leishmaniasis. Mucosal 
leishmaniasis (ML) affects the upper respiratory tract and/
or oral mucosa leading to mucosal ulcerations mainly in the 
hard or soft palate[1]. There are only few reported cases of 
mucosal involvement in leishmaniasis[2], in some cases it 
was seen in post leishmaniasis treatment[3]. This condition 
is often misdiagnosed by health care professionals as 
being fungal infections or oral cancer. A high suspicion 
of oral leishmaniasis should always be kept in patients 
presenting with persistent gingival ulcers or hypertrophy, 
non-responsive to therapy, especially those coming from 
an endemic zone[4]. Early diagnosis and institution of anti-
leishmanial therapy can prevent an irretrievable damage to 
oral and nasal tissues in such cases[5].
2. Case report
  A 17 year old male reported to the department of dental 
surgery complaining of persistent, multiple, painful ulcers 
on the base of tongue and on the palate since 30 d, non-
responsive to any treatment. The ulcers were painful and 
bled on touch, causing a difficulty in eating. He came 
from an area endemic for kala-azar and there was a past 
history of treatment for the same one year back. Patient 
denied any use of tobacco or alcohol, extramarital sexual 
relation or intravenous drug abuse. He looked pale and 
emaciated. Oral examination revealed multiple small ulcers 
on the base of the tongue (Figure 1) and palatal mucosa, 
with marked erythema. These were nodular, swollen, 
raised with irregular margins and all were smaller than a 
centimetre in size. Teeth and gingiva were in good health. 
Neck examination revealed bilaterally enlarged, non-
tender submandibular lymph nodes. Systemic examination 
revealed fever of 101.4 Fahrenheit and palpable spleen. 
Haematological investigations revealed anemia (Hb 
7.6 g/dL), thrombocytopenia (platelet count 70 000/mL), 
slight leukocytosis (total leukocyte count 12 000/mL) 
with polymorphic predominance and albumin:globulin 
(A:G) ratio being 2.6:5.0. Renal function tests and urine 
microscopy was normal. VDRL and HIV tests were negative. 
Residence in an endemic area, past history of treatment 
for kala-azar, palpable splenomegaly and evidence of 
anemia and A:G reversal prompted us to go for rK-39 
immunochromatographic strip test. Not to our surprise, 
it was positive for kala-azar. Aspirates from spleen and 
bone marrow (Figure 2) also depicted the presence of 
Leishmania-Donovan (LD) bodies, confirming the diagnosis. 
Scrapings from the oral ulcer also revealed the presence 
of amastigotes on histopathological examination. Patient 
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was given iv. Amphotericin B (1 mg/kg, qod) for 20 d. During 
treatment no complication was seen. From the 3 rd day of the 
start of the treatment oral mucosal lesions begin to resolve 
and disappeared completely by the 8th day. Fever charting 
of the patient showed slight rise in fever on the 4th and 5th 
day followed by rapid decline to the normal level.
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Figure 1. Depicting the temperature charting of the patient during 
initial phase of amphotericin B therapy.
  Patient was discharged on the 22nd day from the start of 
the treatment. General blood picture was normal at the time 
of discharge and splenomegaly had almost regressed. Patient 
was followed up monthly for three months and three monthly 
for one year. He remained afebrile, with no evidence of 
mucosal lesions or organomegaly.
3. Discussion
  Visceral leishmaniasis(VL) is caused by protozoa 
lieshmania. Around 20 species of leishmania has been 
described. Three major forms are visceral, cutaneous and 
mucocutaneous, each of which is attributed to different 
species of leishmania. In the most parts of the world the 
Phlebotomus species is responsible for transmission, 
while in USA Lutzomyia species is the responsible species 
of sandfly. 500 000 new case of VL are diagnosed every 
year. 90% of which is seen in five countries. These are 
Bangladesh, India, Brazil, Sudan and Nepal. In India, 
Bihar, adjoining areas of West Bengal, Jharkhand and Uttar 
Pradesh account for half of the total cases of leishmaniasis 
throughout the world. ML can be a primary disease 
or could follow an episode of VL. The two have been 
speculated to be connected as they are caused by the same 
parasite. On the contrary, ML in Sudan has been attributed 
to a different subspecies of the Leishmania donovani (L. 
donovani) complex and majority of cases in that region 
presented with isolated mucosal form not accompanied by 
the visceral form[6-8].
  Earlier reports of visceral leishmaniasis presenting as 
oral ulcers in are present[9-12]. In our case the patient had 
previous history of leishmaniasis. This was confirmed by 
his previous bone marrow aspiration report from the district 
hospital where he was admitted, but he did not have 
complete record of treatment given during hospitalization. 
Persistent infection due to inadequate treatment is not 
uncommon. Patients ignore complete medical treatment 
either due to shortage of money or feeling of well being 
following initial therapy. However, possibility of re-
infection could not be ruled out in this case. We chose 
amphotericin B for therapy as the cure rates are excellent 
for patients from Bihar state[13].
  A high suspicion of oral leishmaniasis should always be 
kept in patients presenting with persistent oral ulcers non-
responsive to therapy, especially those coming from an 
endemic zone and having a past history of leishmaniasis 
or persistent fever and splenomegaly. Appropriate 
laboratory tests and histopathological examination is of 
utmost importance for ruling out other diseases clinically 
mimicking ML, such as oronasal tumors, leprosy, 
histoplasmosis, and aspergillosis. Early diagnosis and 
institution of anti-leishmanial therapy can prevent an 
irretrievable damage to oral and nasal tissues in such cases.
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